Literature DB >> 14624073

Recent advances in optic nerve glioma with a focus on the young patient.

David Walker1.   

Abstract

PURPOSE OF REVIEW: Optic tract low-grade gliomas are one of the commonest category of neoplasm presenting in childhood and early adolescence. Recent reports covering their aetiology, imaging techniques, the application of novel radiotherapy techniques and chemotherapy are reported. RECENT
FINDINGS: These tumours are increasingly being seen as markers of enhanced risk in patients and their families for the subsequent development of central nervous system tumours. Modern imaging techniques are being explored for their diagnostic sensitivity and specificity as well as their ability to describe, with greater precision, anatomical boundaries in order to minimize, through conformal techniques, radiation doses to organs at risk within the brain. Increasing numbers of trials of chemotherapy agents are demonstrating efficacy in this tumour category.
SUMMARY: Visual pathway low-grade astrocytomas of childhood are the subject of diverse research into diagnostic aetiological and treatment aspects aimed at tailoring diagnostic and treatment procedures more precisely to the needs of the young patient for this tumour type.

Entities:  

Mesh:

Year:  2003        PMID: 14624073     DOI: 10.1097/01.wco.0000102628.38669.14

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  3 in total

Review 1.  [Orbital tumors].

Authors:  P Papanagiotou; I Q Grunwald; M Politi; C Roth; H Körner; W Reith
Journal:  Radiologe       Date:  2008-12       Impact factor: 0.635

2.  A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma.

Authors:  Maura Massimino; Filippo Spreafico; Daria Riva; Veronica Biassoni; Geraldina Poggi; Carlo Solero; Lorenza Gandola; Lorenzo Genitori; Piergiorgio Modena; Fabio Simonetti; Paolo Potepan; Michela Casanova; Cristina Meazza; Carlo A Clerici; Serena Catania; Iacopo Sardi; Felice Giangaspero
Journal:  J Neurooncol       Date:  2010-02-12       Impact factor: 4.130

Review 3.  Update on the management of familial central nervous system tumor syndromes.

Authors:  Andreas F Hottinger; Yasmin Khakoo
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.